Exhibiting at RSNA, ViVE or HIMSS? Meetings booked before you land
The go-to-market engine for funded healthtech
Win your hospitals and your next round.
Wattar Digital builds the story investors buy and the hospital pipeline that proves it, then runs the system behind both.
For funded medical device, clinical AI, digital health and health IT companies selling to hospitals, health systems and physician groups.
Our founder’s record at EchoNous
Our founder, Mira Wattar, built the physician and hospital pipeline programs behind these numbers at EchoNous, AI handheld ultrasound, first as a consultant and then as VP Global Marketing, from November 2021 to November 2022. They are her results there, not Wattar Digital client results.
- physician and hospital leads
- 15,253
- qualified sales meetings
- 650
- yearly pipeline
- $10M+
Graded twice: by the board and by hospitals.
The day a product is cleared, launched or funded, two audiences start counting. Most teams hire a different firm for each, and the story splits.
Investors want traction
The next round depends on hospital meetings, pilots and contracts, not on the deck alone. The meetings that shape the raise have to start this quarter.
Hospitals buy twice
The value analysis committee approves the purchase on cost and evidence. Then clinicians decide whether it gets used. Win one and ignore the other, and the deal stalls.
Three vendors, three stories
Deck advisors stop at the round, outreach agencies stop at the meeting, strategy firms stop at the plan. Nobody connects them, so what investors hear and what hospitals see drift apart.
Story, pipeline and system, run as one.
One team owns all three, so what investors hear is what hospitals see, and every meeting shows up in the numbers your board reviews.
Investors
and your board
Hospitals
the buying committee
Story
The investor narrative and the hospital value story, written as one, specialty by specialty, from your cleared indications or published evidence.
Our founder led global product launches, trade show programs and acquisition communications at Fujitsu Frontech North America.
- To investors:
- What investors hear
- To hospitals:
- What hospitals see
Pipeline
Meetings with the specialties and buying-committee seats that matter to you, across email, LinkedIn, paid social conversations, calls and conferences.
- Signal-timed email
- Paid social conversations
- Human calls
- Same-day qualification
- Conferences and webinars
How each channel is run
- Signal-timed email
- Triggered by real events at each account and by how each contact responds.
- Connection requests, InMail and sponsored messages, personalized by specialty and role.
- Paid social conversations
- LinkedIn and Meta ads that start a conversation with the right clinicians, answered by a person, instead of sending them to a form.
- Human calls
- Made by people, to business lines. Never AI voices.
- Same-day qualification
- A person answers questions and routes qualified buyers to a meeting the same day.
- Conferences and webinars
- Meetings booked before the show, and a quarterly clinical-champion webinar.
At EchoNous, first as a consultant and then as VP Global Marketing, our founder built programs that produced 650 qualified sales meetings with physicians and hospitals.
- To hospitals:
- Every channel
System
Signals, scoring, outreach and every meeting in one live portal, so you see the launch daily and your board sees it monthly.
Behind every touch
- Segmentation by specialty, role and buying stage
- Lead scoring with sync to your CRM
- Attribution across every touchpoint, not just the last one
- Continuous tests on message, timing and creative
We run the same system on ourselves: new FDA clearances and funding filings are pulled every day, and every account is scored before anyone is contacted.
- From hospitals:
- Every meeting
- To investors:
- The numbers your board reviews
Four seats we plan every launch around.
A clinician who loves the demo usually cannot buy your device alone. In practice we plan around four seats in the buying group, each asking a different question, and adjust the map to how each hospital actually buys.
Adoption
Clinical champion
Will my team use it, and does it make care better?
Sponsorship
Department chair
Does it fit our service line plan and budget this year?
The value analysis committee approves the purchase. Clinicians decide whether it gets used. A launch has to win both.
Cost
Supply chain
What does it cost all in, and what does it replace?
Approval
Value analysis committee
Is the evidence strong enough to justify the spend?
The specialties and seats that matter to you.
Behind the four seats there are often many more people. We map the ones that matter for your product and write to each in their own terms, across hospitals, health systems, physician groups and outpatient centers.
Decision makers
- Chief medical officer
- Chief nursing officer
- CIO and CMIO
- CFO and finance
- Department chairs
- Service line directors
- Practice administrators
- Nurse managers
- Supply chain and purchasing
- Value analysis committees
- Biomedical engineering
- IT security and informatics
Clinical specialties
- Emergency medicine
- Critical care
- Hospital medicine
- Radiology and imaging
- Cardiology
- Oncology
- Surgery and perioperative
- Anesthesiology
- Neurology
- Orthopedics
- Obstetrics and NICU
- Primary care
- Nursing
Five ways to work together.
Every engagement starts with a diagnostic. A Sprint fits one show. Readiness, then the Engine, fit a full launch.
Launch Diagnostic
30-minute call, by application only
Free
A senior read on your buyers, your story and your timing, and a plain answer on whether we can help.
Launch and Raise Readiness
4 weeks
$25,000
Your investor story and your hospital story as one, scored health systems, committee maps, message tests and a 90-day plan.
Half the fee is credited to the Go-to-Market Engine if you start it within 30 days.
Go-to-Market Engine
Quarterly engagement, billed in advance and renewed quarter by quarter, with a monthly review
$15,000 to $25,000 a month
Always-on pipeline to the buying seats that matter, founder content, conference meetings, a live portal and a monthly traction report.
Go-to-Market Leadership
Quarterly engagement, billed in advance and renewed quarter by quarter
$25,000 to $40,000 a month
The Engine plus our founder as your fractional go-to-market leader, from positioning to board-ready reporting.
Conference Meeting Sprint
Eight weeks around one show
$12,000
Meetings with hospital buyers booked before you land, at RSNA, ViVE, HIMSS or your specialty meeting, and followed up after the show.
A senior operator leads every launch.
We take on launches one at a time, so each one has senior attention from the first week.
Questions founders ask first.
What does Wattar Digital do?
Wattar Digital builds the story investors buy and the hospital pipeline that proves it. We write the investor and hospital story as one, find the health systems most likely to buy, map each buying committee across every relevant specialty and role, write the value story that committee needs, and book meetings with its members through email, LinkedIn, paid social and human calls. Every account and meeting is visible in a live client portal.
Who is Wattar Digital for?
Founders, CEOs and go-to-market (GTM) leaders at healthtech companies that sell to hospitals, health systems or physician groups: medical devices, clinical AI, digital health and health IT. They have a cleared or launching product, a lean team, a go-to-market budget and a board that wants hospital traction. Most come to us just after a clearance, a launch or a new round, when the next raise depends on that traction.
Can you guarantee meetings?
No. Hospital meetings depend on clinical fit, timing and each committee’s own calendar, and no outside team controls those. Meeting targets are goals we plan and report against, never guarantees. On a Conference Meeting Sprint we put the target in writing before you pay, and if we miss it we keep working after the show at no extra fee, for up to 60 days. That is more work, not a refund. What we commit to everywhere is the work: the list, the outreach, the follow-up, and every account and meeting reported so you can judge it yourself.
Who owns the lists and content?
You do. Every list, message and asset is yours, during the engagement and after it.
How do you handle clinical and regulatory claims?
For regulated products we write only from your cleared indications, and for every product your team approves every claim before anything is sent. If a message cannot be supported by the clearance or your published evidence, it is not used.
Do you use patient data?
Never. We work only with professional contact data: the names, roles and business contact details of hospital staff. No patient information enters our work.
Do you use AI voices or texting?
No. Calls are made by people, to business lines only, and we never send cold text messages. When a clinician starts a conversation from one of our ads, a person answers. AI powers the research and the pipeline engine underneath. The conversations are human.
How is pricing structured?
The Launch Diagnostic is free. A Conference Meeting Sprint is $12,000 a show. Launch and Raise Readiness is $25,000, with half of it credited to the Go-to-Market Engine if you start it within 30 days. The Go-to-Market Engine runs about $15,000 to $25,000 a month, and Go-to-Market Leadership, with our founder as your fractional go-to-market leader, about $25,000 to $40,000 a month; both are quarterly engagements, billed in advance and renewed quarter by quarter. A custom intelligence platform is scoped and priced on its own. Paid engagements are paid in advance, and nothing is tied to your revenue.
Who actually does the work?
A senior operator leads every launch from the first week; the research, the lists and the sending run on our own system behind them. Conference Meeting Sprints run on their own calendar alongside the launches.
Field guides for funded healthtech.
What we have learned about how hospitals buy, written for CEOs and go-to-market leaders.
Field guide
From clearance to contract: the first 90 days.
For CEOs who just cleared, launched or raised.
Field guide
Every seat at the table: who usually buys in a hospital.
For go-to-market leaders building a first target list.